دانلود کتاب راهنمای تمرین قلبی انکولوژی: همگام با بیماری قلبی براونوالد
Cardio-Oncology Practice Manual: A Companion to Braunwald’s Heart Disease, 1ed

Today’s patients have unique cardiologic needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce acute side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in effective patient care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular diseases due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers.

• Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide―ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists.
• Offers templated and streamlined content for quick retrieval, with key point summaries for each major section.
• Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects.
• Features “Central Illustrations” for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies.
• Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies.
• Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies

Contents

۱. The cardio-oncology clinic: Goals, scope, and focus of practice
۲. Key points of cardio-oncology evaluation before cancer therapy
۳. Cardiovascular risks of chemotherapy
۴. Radiation therapy cardiovascular risks
۵. Bone marrow transplantation risks
۶. Surgical risks
۷. Prevention of heart failure and cardiomyopathy in patients with cancer
۸. Vascular disease prevention: Before cancer therapy
۹. Thromboembolic disease prevention before cancer therapy
۱۰. Arrhythmia prevention and device management: Before cancer therapy
۱۱. Hypertension and renal disease prevention before cancer therapy
۱۲. Prevention and management of pulmonary conditions in patients with cancer before therapy
۱۳. Cardiopulmonary exercise for management of cardiovascular toxicity
۱۴. Key points of cardio-oncology evaluation during cancer therapy
۱۵. Diagnosis and management of cardiomyopathy and heart failure during cancer treatment
۱۶. Structural heart disease management during cancer treatment
۱۷. Vascular disease during cancer therapy
۱۸. Thromboembolic disease treatment during cancer therapy
۱۹. Arrhythmia and device assessment during cancer treatments
۲۰. Hypertension and renal disease during anti-cancer therapies
۲۱. Pulmonary disease during cancer therapy
۲۲. Cardiovascular testing in patient with cancer
۲۳. Key points of cardio-oncology evaluation after cancer therapy
۲۴. Cancer survivorship and comorbidity disease risk after cancer treatment
۲۵. Long-term complications of chemotherapy
۲۶. Long-term consequences of radiation therapy
۲۷. Prevention and management of cardiomyopathy and heart failure in cancer survivors
۲۸. Structural heart disease prevention and management in cancer survivors
۲۹. Vascular disease prevention and management after cancer therapy
۳۰. Prevention of VTE after initial presentation and cancer treatment
۳۱. Arrhythmia prevention and management in cancer survivors
۳۲. Hypertension and renal failure prevention and management after cancer therapy
۳۳. Monitoring for and management of delayed complications after cancer therapy
۳۴. Cardio-oncology rehabilitation for patients with cancer and survivors
۳۵. Breast cancer
۳۶. Gynecologic malignancies
۳۷. Prostate and testicular cancer
۳۸. Renal and urinary bladder cancer
۳۹. Lung cancer
۴۰. Colorectal cancer
۴۱. Esophageal and gastric cancer
۴۲. Hepatobiliary carcinomas
۴۳. Pancreatic cancer
۴۴. Cutaneous melanoma
۴۵. Head and neck cancers
۴۶. Thyroid cancer
۴۷. Glioblastoma
۴۸. Introduction to the management of soft tissue sarcomas
۴۹. Acute and chronic leukemias
۵۰. Lymphomas
۵۱. Multiple myeloma and cardiac amyloidosis
۵۲. Carcinoid tumors and carcinoid heart disease
۵۳. Neoplasms and the heart
۵۴. Cancer therapeutic drug guide